Alex Lugovoy
Corporate Officer/Principal bei ADIAL PHARMACEUTICALS, INC.
Profil
Alex Lugovoy is the founder of Dobrin Consulting.
He is currently the Chief Business Officer at Adial Pharmaceuticals, Inc. Mr. Lugovoy previously worked as a Senior Manager at Indivior PLC and as the Head of Business Development at Reckitt Benckiser Pharmaceuticals, Inc. from 2007 to 2012.
He holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Colgate University.
Aktive Positionen von Alex Lugovoy
| Unternehmen | Position | Beginn |
|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 11.04.2019 |
| Dobrin Consulting | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Alex Lugovoy
| Unternehmen | Position | Ende |
|---|---|---|
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Corporate Officer/Principal | 01.12.2012 |
| INDIVIOR PLC | Corporate Officer/Principal | - |
Ausbildung von Alex Lugovoy
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Colgate University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADIAL PHARMACEUTICALS, INC. | Health Technology |
| INDIVIOR PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Dobrin Consulting | |
Reckitt Benckiser Pharmaceuticals, Inc.
Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Health Technology |
